3 terminated. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Terminated 3 |
Follow Memory Impairment: new trials by email Literature Review of Memory Impairment trials Research Report on Memory Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exercise and Learning and Memory in Multiple Sclerosis Treadmill Walking Exercise Training, Stretching-and-toning Exercise Training - Multiple Sclerosis, Physical Activity | Not applicable | Terminated | University of Alabama at Birmingham | 14 | 2018-12-01 | 2021-10-11 |
| Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder Computerized brain fitness training, Yoga, Wellness Education - Mild Cognitive Impairment, Memory Disorders | Not applicable | Terminated | University of Florida | 5 | 2017-03-23 | 2022-07-06 |
| Donepezil Memory Preservation Post ECT Donepezil, Placebo - Memory Impairment | Not applicable | Terminated | Porter Adventist Hospital | 12 | 2015-09-24 | 2018-07-06 |
Memory Disorders (3) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Dementia (1) · Motor Activity (1) · Multiple Sclerosis (1) · Neurocognitive Disorders (1)
Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Behavior (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Mental Disorders (1)
Cognitive Training (1) · Donepezil (1) · Self-Help Groups (1) · Sucrose (1) · Yoga (1)
Porter Adventist Hospital (1) · University of Alabama at Birmingham (1) · University of Florida (1)
United States (3)
Brian M Sandroff, PhD (1) · Glenn Smith, Ph. D (1) · Robin Wackernah, Pharm.D. (1)